Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis
Open Access
- 25 October 2012
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 52 (2) , 191-201
Abstract
Copy number changes or reduced expression of the Neuron navigator 3 (NAV3) gene occurs in neuroblastomas and malignancies of epithelial or lymphoid origin. To elucidate whether NAV3 has a role in the tumorigenesis of nervous system tumors in general, we studied central and peripheral nervous system tumors for NAV3 copy number changes. In search for common tumorigenic denominators, we analyzed 113 central and peripheral nervous system tumors, including glial tumors (grades I–IV gliomas), medulloblastomas, and neuroblastomas. NAV3 copy number changes were studied by fluorescence in situ hybridization and correlated to survival analyses. To identify target genes of NAV3 deletion, NAV3 was silenced by siRNA in glioblastoma cell lines and gene expression profiles were analyzed by Agilent 4×44k dual-color microarrays. Selected upregulations were confirmed by immunohistochemistry and quantitative polymerase chain reaction. We found NAV3 amplifications to dominate in neuronally differentiated tumors, whereas glial tumors showed almost equal proportions of NAV3 deletion and amplification. However, Grade IV gliomas had more frequent NAV3 deletions than grades I–III gliomas. Silencing of NAV3 in glioma cell lines led to the upregulation of receptor genes associated with gonadotropin-releasing hormone and Jak-Stat signaling pathways. Kaplan–Meier analysis of the entire clinical tumor material showed association between NAV3 amplifications and favorable prognosis, as well as NAV3 deletions and unfavorable prognosis. With Cox regression model, a hazard ratio of 0.51 was observed for NAV3 amplifications and 1.36 for NAV3 deletions. We conclude that NAV3 may be a potential new prognostic biomarker and a potential therapeutic target.Keywords
This publication has 37 references indexed in Scilit:
- Potential role of a navigator gene NAV3 in colorectal cancerBritish Journal of Cancer, 2011
- Jekyll and Hyde: the role of the microenvironment on the progression of cancerThe Journal of Pathology, 2010
- Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/β-Catenin Pathway Cross-Talk and Suppress Medulloblastoma GrowthCancer Research, 2010
- A Network Model of a Cooperative Genetic Landscape in Brain TumorsJAMA, 2009
- Emerging Targets of the GnRH Receptor: Novel Interactions with Wnt Signalling MediatorsNeuroendocrinology, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Clinicopathological Characterization and Genomic Aberrations in Subcutaneous Panniculitis-Like T-Cell LymphomaJournal of Investigative Dermatology, 2008
- Cutaneous T‐cell lymphoma‐associated lung cancers show chromosomal aberrations differing from primary lung cancerGenes, Chromosomes and Cancer, 2007
- Two Sides of the Same Coin: Wnt Signaling in Neurodegeneration and Neuro-OncologyBioscience Reports, 2005
- Mechanisms and Molecules of the Mitotic SpindleCurrent Biology, 2004